ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
60.38
-0.67 (-1.10%)
Sep 19, 2024, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Market Cap
ANI Pharmaceuticals has a market cap or net worth of $1.18 billion as of September 19, 2024. Its market cap has decreased by -7.55% in one year.
Market Cap
1.18B
Enterprise Value
1.25B
1-Year Change
-7.55%
Ranking
Category
Stock Price
$60.38
Market Cap Chart
Since May 5, 2000, ANI Pharmaceuticals's market cap has increased from $31.10M to $1.18B, an increase of 3,689.39%. That is a compound annual growth rate of 16.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 18, 2024 | 1.28B | 13.99% |
Dec 29, 2023 | 1.13B | 60.39% |
Dec 30, 2022 | 702.60M | 19.57% |
Dec 31, 2021 | 587.60M | 63.72% |
Dec 31, 2020 | 358.90M | -51.87% |
Dec 31, 2019 | 745.70M | 39.70% |
Dec 31, 2018 | 533.80M | -28.93% |
Dec 29, 2017 | 751.10M | 6.89% |
Dec 30, 2016 | 702.70M | 35.42% |
Dec 31, 2015 | 518.90M | -18.78% |
Dec 31, 2014 | 638.90M | 235.20% |
Dec 31, 2013 | 190.60M | 533.22% |
Dec 31, 2012 | 30.10M | -45.47% |
Dec 30, 2011 | 55.20M | -52.74% |
Dec 31, 2010 | 116.80M | 50.13% |
Dec 31, 2009 | 77.80M | 183.94% |
Dec 31, 2008 | 27.40M | -73.32% |
Dec 31, 2007 | 102.70M | 58.73% |
Dec 29, 2006 | 64.70M | -8.62% |
Dec 30, 2005 | 70.80M | -29.83% |
Dec 31, 2004 | 100.90M | 79.86% |
Dec 31, 2003 | 56.10M | 95.47% |
Dec 31, 2002 | 28.70M | -46.55% |
Dec 31, 2001 | 53.70M | 72.12% |
Dec 29, 2000 | 31.20M | 0.32% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Arcutis Biotherapeutics | 1.21B |
Collegium Pharmaceutical | 1.20B |
Tarsus Pharmaceuticals | 1.18B |
Prothena Corporation | 1.18B |
Tyra Biosciences | 1.18B |
Cogent Biosciences | 1.15B |
OPKO Health | 1.15B |
AnaptysBio | 1.13B |